Deciphering the suppressive immune microenvironment of prostate cancer based on CD4+regulatory T cells: Implications for prognosis and therapy prediction

被引：33
|
作者：
Ge, Qintao [1 ,2 ,3 ]
Zhao, Zhijie [4 ]
Li, Xiao [1 ,2 ,3 ]
Yang, Feixiang [1 ,2 ,3 ]
Zhang, Meng [1 ,2 ,3 ]
Hao, Zongyao [1 ,2 ,3 ]
Liang, Chaozhao [1 ,2 ,3 ,5 ]
Meng, Jialin [1 ,2 ,3 ,5 ]
机构：
[1] Anhui Med Univ, Affiliated Hosp 1, Dept Urol, Hefei 230001, Peoples R China
[2] Anhui Med Univ, Inst Urol, Hefei, Peoples R China
[3] Anhui Med Univ, Anhui Prov Key Lab Urol & Androl Dis Res & Med Tra, Hefei, Peoples R China
[4] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, Sch Med, Shanghai, Peoples R China
[5] Anhui Prov Inst Translat Med, Hefei, Peoples R China
来源：
CLINICAL AND TRANSLATIONAL MEDICINE | 2024年 / 14卷 / 01期
关键词：
D O I：
10.1002/ctm2.1552
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：7
相关论文
共 50 条
  • [41] Analysis of circulating regulatory T cells (CD4+CD25+CD127-) after cryosurgery in prostate cancer
    Si, Tong-Guo
    Wang, Jun-Ping
    Guo, Zhi
    ASIAN JOURNAL OF ANDROLOGY, 2013, 15 (04) : 461 - 465
  • [42] Correlation between Tumor Microenvironment and Immune Subtypes Based on CD8 T Cells Enhancing Personalized Therapy of Gastric Cancer
    Wu, Jianyu
    Xiao, Yajie
    Lu, Weiqi
    Zhang, Zijing
    Yang, Haigan
    Cui, Xiaoli
    Wu, Dongfang
    Chen, Yuzhong
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [43] Human CD4+CD25+Regulatory T Cells Are Sensitive to Low Dose Cyclophosphamide: Implications for the Immune Response
    Heylmann, Daniel
    Bauer, Martina
    Becker, Huong
    van Gool, Stefaan
    Bacher, Nicole
    Steinbrink, Kerstin
    Kaina, Bernd
    PLOS ONE, 2013, 8 (12):
  • [44] Immune cell analyses of the tumor microenvironment in prostate cancer highlight infiltrating regulatory T cells and macrophages as adverse prognostic factors
    Andersen, Line B.
    Norgaard, Maibritt
    Rasmussen, Martin
    Fredsoe, Jacob
    Borre, Michael
    Ulhoi, Benedicte P.
    Sorensen, Karina D.
    JOURNAL OF PATHOLOGY, 2021, 255 (02): : 155 - 165
  • [45] Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer
    Wang, RF
    SEMINARS IN CANCER BIOLOGY, 2006, 16 (01) : 73 - 79
  • [46] CD25+CD4+ regulatory T-cells in cancer
    Linehan, DC
    Goedegebuure, PS
    IMMUNOLOGIC RESEARCH, 2005, 32 (1-3) : 155 - 168
  • [47] NKG2D+CD4+T Cells with Immune Suppressive Property Increase in Patients with Colorectal Cancer
    Yamamoto, Manabu
    Saito, Hiroaki
    Kihara, Kyoichi
    Katano, Kuniyuki
    Ikeguchi, Masahide
    YONAGO ACTA MEDICA, 2010, 53 (01) : 9 - 16
  • [48] CD25+CD4+ regulatory T-cells in cancer
    David C. Linehan
    Peter S. Goedegebuure
    Immunologic Research, 2005, 32 : 155 - 168
  • [49] Prognostic Impact of Cytotoxic CD4 T Cells in Tumor Immune Microenvironment of Patients with Breast Cancer
    Shohdy, Kyrillus S.
    Almeldin, Doaa S.
    Ghaly, Ramy
    Kassem, Loay
    Pagani, Olivia
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2022, 5 (01) : 7 - 9
  • [50] Increased CCR4-positive regulatory T cells in biopsy specimen of poor prognosis prostate cancer
    Watanabe, Masahito
    Kanao, Kent
    Suzuki, Susumu
    Muramatsu, Hiroyuki
    Morinaga, Shingo
    Kajikawa, Keishi
    Kobayashi, Ikuo
    Nishikawa, Genya
    Kato, Yoshiharu
    Nakamura, Kogenta
    Yoshikawa, Kazuhiro
    Ueda, Ryuzo
    Sumitomo, Makoto
    CANCER RESEARCH, 2017, 77
12345